NCT05310747 is a NA clinical trial of Artwork present in Chronic Pain, sponsored by University of California, Davis.

Who is sponsoring NCT05310747?

NCT05310747 is sponsored by University of California, Davis.

What drugs are being tested in NCT05310747?

Interventions in NCT05310747: Artwork present, Artwork absent, Social connection high, Social connection low.

What condition does NCT05310747 study?

NCT05310747 studies Chronic Pain, Social Disconnection.

Is NCT05310747 still recruiting?

NCT05310747 is currently completed. Last updated 23 April 2025.

Last reviewed 2025-04-23 · How we verify

NCT05310747

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Can Exposure to Inclusive Virtual Art Decrease Pain and Social Disconnection Among Individuals Living With Chronic Pain?

Completed NA Last updated 23 April 2025

What this trial tests

NA trial testing Artwork present in Chronic Pain in 311 participants. Completed in 6 January 2023.

Timeline

7 October 2022

Primary endpoint
6 January 2023

6 January 2023

Quick facts

Lead sponsor	University of California, Davis
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	triple
Primary purpose	treatment
Enrollment	311
Start date	7 October 2022
Primary completion	6 January 2023
Estimated completion	6 January 2023
Sites	1 location across United States

Drugs / interventions tested

Artwork present
Artwork absent
Social connection high
Social connection low

Conditions studied

Chronic Pain — all drugs for Chronic Pain →
Social Disconnection — all drugs for Social Disconnection →

Sponsor

University of California, Davis

Who can join

18 and older, any sex, with Chronic Pain or Social Disconnection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study is an experimental intervention to test for the effects of exposure to art by means of a virtual museum visit. It examines the fundamental question of whether exposure to virtual art can alleviate pain. Google Arts \& Culture has digitized the collections of over 2,000 museums, art galleries, and other cultural institutions. The platform is free and allows 'visitors' to explore art from around the world. For this study, the PIs have chosen artwork from this collection and created a virtual museum gallery such that research participants will visit the museum with or without art (i.e., we will remove all art from the virtual galleries). In addition, we hypothesize that individuals primed to experience social connection prior to art exposure will experience lower perceived social disconnection and pain than those who are not primed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Using Digital Art and Attachment Priming in a Web-Based Serious Game to Reduce Pain and Social Disconnection in Individuals With Chronic Pain and Loneliness: Randomized Controlled Trial.
Peña J, Koebner I, Weisman W. · · 2024 · cited 2× · PMID 39602564 · DOI 10.2196/52294

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other University of California, Davis trials

Trials by the same sponsor.

NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05310747 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
Last refreshed: 23 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05310747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing